APP and Alzheimer disease: Not surprisingly, there are alterations in white matter and white matter networks by DTI in preclinical AD (cognitively normal, positive florbetapir-PET or abnormal CSF Abeta) (Molinuevo et al., 2014; Fischer et al., 2015).